Clinical Trial Update: Efficacy and Safety of Nerve Growth Factor or Edaravone on Alcohol-induced Brain Injury [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating nerve growth factor or edaravone for alcohol-induced brain injury, focusing on efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol-induced Brain Injury

Drugs mentioned

• Edaravone (Edaravone)
• Nerve Growth Factor (nerve growth factor)

Snippet

Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Conditions: Alcohol-induced Brain Injury | Phase 2 | Status: UNKNOWN